The Food and Drug Administration (FDA) is unsure whether to push forward and resume a coronavirus vaccine trial that was stopped after a participant suffered spinal cord damage.
The National Institutes of Health (NIH) is investigating the case regarding the individual but is also concerned about the trial going forward, according to CNN.
“The highest levels of NIH are very concerned,” Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke (an NIH division) told CNN. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.”
<img aria-describedby="caption-attachment-7006454" class="size-full wp-image-7006454" src="https://dailytruthreport.com/wp-content/uploads/2020/09/GettyImages-1228456294-scaled-1.jpg" alt="A laboratory technician takes part in filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 at the Italian biologics manufacturing facility of multinational corporation Catalent in Anagni, southeast of Rome, during the COVID-19 infection, caused by the novel coronavirus. – Catalent Biologics manufacturing facility in Anagni, Italy will serve as the launch facility for the large-scale production and supply of the University